JP2024023235A5 - - Google Patents

Download PDF

Info

Publication number
JP2024023235A5
JP2024023235A5 JP2023189307A JP2023189307A JP2024023235A5 JP 2024023235 A5 JP2024023235 A5 JP 2024023235A5 JP 2023189307 A JP2023189307 A JP 2023189307A JP 2023189307 A JP2023189307 A JP 2023189307A JP 2024023235 A5 JP2024023235 A5 JP 2024023235A5
Authority
JP
Japan
Prior art keywords
oligomeric compound
stranded oligomeric
modified oligonucleotide
wing segment
stranded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023189307A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024023235A (ja
Filing date
Publication date
Priority claimed from JP2020523976A external-priority patent/JP7431728B2/ja
Application filed filed Critical
Publication of JP2024023235A publication Critical patent/JP2024023235A/ja
Publication of JP2024023235A5 publication Critical patent/JP2024023235A5/ja
Pending legal-status Critical Current

Links

JP2023189307A 2017-10-31 2023-11-06 ENaC発現の調節因子 Pending JP2024023235A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201762579640P 2017-10-31 2017-10-31
US62/579,640 2017-10-31
US201862743669P 2018-10-10 2018-10-10
US62/743,669 2018-10-10
JP2020523976A JP7431728B2 (ja) 2017-10-31 2018-10-31 ENaC発現の調節因子
PCT/US2018/058354 WO2019089692A1 (en) 2017-10-31 2018-10-31 MODULATORS OF ENaC EXPRESSION

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020523976A Division JP7431728B2 (ja) 2017-10-31 2018-10-31 ENaC発現の調節因子

Publications (2)

Publication Number Publication Date
JP2024023235A JP2024023235A (ja) 2024-02-21
JP2024023235A5 true JP2024023235A5 (cg-RX-API-DMAC7.html) 2024-05-14

Family

ID=66333370

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020523976A Active JP7431728B2 (ja) 2017-10-31 2018-10-31 ENaC発現の調節因子
JP2023189307A Pending JP2024023235A (ja) 2017-10-31 2023-11-06 ENaC発現の調節因子

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020523976A Active JP7431728B2 (ja) 2017-10-31 2018-10-31 ENaC発現の調節因子

Country Status (16)

Country Link
US (2) US20210180057A1 (cg-RX-API-DMAC7.html)
EP (1) EP3703702A4 (cg-RX-API-DMAC7.html)
JP (2) JP7431728B2 (cg-RX-API-DMAC7.html)
KR (1) KR20200079505A (cg-RX-API-DMAC7.html)
CN (1) CN111372594A (cg-RX-API-DMAC7.html)
AU (1) AU2018357932A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020005038A2 (cg-RX-API-DMAC7.html)
CA (1) CA3074739A1 (cg-RX-API-DMAC7.html)
CL (1) CL2020000586A1 (cg-RX-API-DMAC7.html)
CO (1) CO2020003134A2 (cg-RX-API-DMAC7.html)
IL (1) IL274231A (cg-RX-API-DMAC7.html)
MX (1) MX2020003554A (cg-RX-API-DMAC7.html)
PE (1) PE20200749A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202001863PA (cg-RX-API-DMAC7.html)
TW (1) TW201927313A (cg-RX-API-DMAC7.html)
WO (1) WO2019089692A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3990119A4 (en) * 2019-06-26 2024-03-27 Fred Hutchinson Cancer Center METHODS AND COMPOSITIONS COMPRISING BRD9 ACTIVATION THERAPIES FOR THE TREATMENT OF CANCERS AND RELATED DISORDERS
PL3956450T3 (pl) 2019-07-26 2025-12-22 Ionis Pharmaceuticals, Inc. Związki i sposoby modulowania gfap

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR066984A1 (es) * 2007-06-15 2009-09-23 Novartis Ag Inhibicion de la expresion de la subunidad alfa del canal epitelial de sodio (enac) por medio de arni (arn de interferencia)
EP2304057B1 (en) * 2008-06-17 2014-09-17 Signature Diagnostics AG Method for the detection of ovarian cancer
US9574193B2 (en) * 2012-05-17 2017-02-21 Ionis Pharmaceuticals, Inc. Methods and compositions for modulating apolipoprotein (a) expression
US10590485B2 (en) * 2014-05-29 2020-03-17 Geneticure Llc Therapeutic regimen for hypertension

Similar Documents

Publication Publication Date Title
Pley et al. Model for an RNA tertiary interaction from the structure of an intermolecular complex between a GAAA tetraloop and an RNA helix
CN102123716B (zh) 用于治疗病毒感染的化合物和方法
CA2163520C (en) L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents
EP0748330B1 (en) L-nucleosides for the treatment of hepatitis b-virus and epstein-bar virus
TWI313176B (en) Pharmaceutical compositions for treating diseases mediated by the hepatitis virus
CN100387237C (zh) 用于治疗乙型肝炎的β-L-2'-脱氧-核苷
US5631239A (en) L-2',3'-dideoxy nucleoside analogs as anti-Hepatitis B (HBV) agents
US5756478A (en) Method for reducing toxicity of D-nucleoside analogs with L-nucleosides
CN108350454A (zh) 等位基因选择性基因编辑及其用途
TW202113079A (zh) 經修飾之間隙子寡核苷酸及其使用方法
JPH05505101A (ja) オリゴヌクレオチド療法における三重らせん形成
JP2022501024A5 (cg-RX-API-DMAC7.html)
JP2024516096A5 (cg-RX-API-DMAC7.html)
JP2022526267A5 (cg-RX-API-DMAC7.html)
JP2010500291A5 (cg-RX-API-DMAC7.html)
JP2025511183A5 (cg-RX-API-DMAC7.html)
JP2023549563A5 (cg-RX-API-DMAC7.html)
EP0703787A1 (en) Cell growth regulators
JP2024520522A5 (cg-RX-API-DMAC7.html)
Meisel et al. Inhibition of hepatitis B virus DNA polymerase by 3′‐fluorothymidine triphosphate and other modified nucleoside triphosphate analogs
JP2021500903A5 (cg-RX-API-DMAC7.html)
Porumb et al. Triple-helices targeted to the polypurine tract of a murine retrovirus
JP2023501352A5 (cg-RX-API-DMAC7.html)
Corneo et al. Inhibition of DNA restriction enzyme digestion by anthracyclines
HK1013257B (en) L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents